|
Revenue
|
| -0.22M |
|
Research & Development
|
4.93M | 6.42M |
|
Selling, General & Administrative
|
8.15M | 8.78M |
|
Restructuring Costs
|
1.85M | 2.20M |
|
Other Operating Expenses
|
5.65M | 6.12M |
|
Operating Expenses
|
20.57M | 23.52M |
|
Operating Income
|
-20.57M | -23.52M |
|
EBIT
|
-20.57M | -23.52M |
|
Interest & Investment Income
|
| 0.04M |
|
Non Operating Income
|
| -0.18M |
|
EBT
|
-20.57M | -23.70M |
|
Tax Provisions
|
0.58M | 1.06M |
|
Profit After Tax
|
-21.15M | -24.76M |
|
Income from Continuing Operations
|
-21.15M | -24.76M |
|
Consolidated Net Income
|
-21.15M | -24.76M |
|
Income towards Parent Company
|
-21.15M | -24.76M |
|
Net Income towards Common Stockholders
|
-21.15M | -24.76M |
|
EPS (Basic)
|
-0.31 | -0.34 |
|
EPS (Weighted Average and Diluted)
|
-0.31 | -0.34 |
|
Shares Outstanding (Weighted Average)
|
71.72M | 78.37M |
|
EBITDA
|
-20.57M | -23.52M |
|
Interest Expenses
|
| 0.22M |